Ultrasound in Children with Localized Scleroderma (Morphea)
Part of Skin clinical trials.
This study uses a special ultrasound (elastography) to measure how stiff or thick your skin patches are over time. It helps doctors understand morphea better and see if treatment is working, with no extra needles or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 0–18 years old when your skin changes first started.
- You need a diagnosis of localized scleroderma (morphea) from a pediatric rheumatologist or dermatologist.
- You have at least one skin patch that is either active (changing) or inactive (stable), but not one active and one inactive at the same time.
- All skin patches are located on your body, not on your face or head.
- You do not have other medical conditions like systemic sclerosis or juvenile arthritis.
- You and your parent/guardian can cooperate with the ultrasound and fill out a short health history form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This study uses ultrasound and nerve tests to look at how systemic sclerosis (scleroderma) affects the hands. It aims to find what causes hand problems and may help improve care for people with this condition.
This study tests if a special exercise program based on your body and mind can help people with scleroderma feel better. It is for both children (ages 7-18) and adults.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study is building a registry (a group record) of people with morphea and collecting DNA samples to help researchers learn more about the condition. It may help by improving understanding of causes, patterns, and future treatments.
Hear when a new Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.